Completed NA INTERVENTIONAL 3-arm NCT01755000

Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

A Pilot Feasibility Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

Sponsor: Washington University School of Medicine

Conditions Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Paraproteinemias

Updated 7 times since 2017 Last updated: Aug 30, 2013 Started: Dec 31, 2012 Primary completion: Apr 30, 2013 Completion: Apr 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Leukemia and Lymphoma and is currently completed. Washington University School of Medicine leads this study, which shows 7 recorded versions since 2012 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Washington University School of Medicine

Data source: Washington University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• St Louis, United States